Chembio Diagnostic Inc (CEMI):医療機器:M&Aディール及び事業提携情報

【英語タイトル】Chembio Diagnostic Inc (CEMI) - Medical Equipment - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C7039)・商品コード:DATA904C7039
・発行会社(調査会社):GlobalData
・発行日:2018年10月
・ページ数:54
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Chembio Diagnostic Inc (Chembio) develops, manufactures, markets and licenses point-of-care diagnostic (POCs) tests for the detection of infectious diseases. The company offers products to prevent the spread of infectious diseases with solutions like Dual Path Platform (DPP). Its DPP technology is used to treat infectious diseases such as HIV, Ebola, syphilis, Zika, malaria and febrile illness. Chembio also offers veterinary diagnostics. The company offers its products to medical laboratories and hospitals, non-governmental organizations, governmental and public health entities, medical professionals and retailers. The company distributes its products through a network of distributors worldwide. Chembio is headquartered in Medford, New York, the US.

Chembio Diagnostic Inc (CEMI) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Chembio Diagnostic Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Chembio Diagnostic Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Chembio Diagnostic Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Chembio Diagnostic Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Chembio Diagnostic Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Chembio Diagnostic Inc, Medical Equipment, Deal Details 12
Asset Purchase 12
Chembio Diagnostics Acquires Rights to SURE CHECK(R) HIV 1/2 Assay From StatSure Diagnostic Systems 12
Partnerships 13
Chembio Diagnostics Enters Into Licensing Agreement With RVR Diagnostics 13
Genisphere Enters Into Licensing Agreement With Chembio Diagnostics 14
Chembio Diagnostic Enters into Agreement with Bio Manguinhos 15
Chembio Diagnostic Enters into Agreement with LumiraDx 16
Chembio Diagnostic Enters into Agreement with AstraZeneca 17
Chembio Diagnostics Enters into Agreement with FIND 18
Chembio Diagnostics Enters into Co-Development Agreement with Bio-Manguinhos 19
Chembio Diagnostics Enters into Agreement with Perseus Science 20
Chembio Diagnostics Enters into Co-Development Agreement with Integrated BioTherapeutics 21
Chembio Diagnostics Enters into Agreement to Develop POC Diagnostic Tests for Dengue Fever Virus and Specific Type of Cancer 22
Chembio Enters Into Distribution Agreement With Labtest For Dual Path Platform Products 23
Equity Offering 24
Chembio Diagnostic Plans to Raise USD50 Million in Public Offering of Securities 24
Chembio Diagnostics Raises USD12 Million in Public Offering of Shares 25
Chembio Diagnostics Raises USD13.8 Million in Public Offering of Shares 26
Chembio Diagnostics Completes Public Offering Of Common Stock For US$6 Million 28
Acquisition 29
Chembio Diagnostics Acquires RVR Diagnostics 29
Chembio Diagnostic Inc – Key Competitors 30
Chembio Diagnostic Inc – Key Employees 31
Chembio Diagnostic Inc – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 33
Financial Announcements 33
Aug 08, 2018: Chembio Diagnostics reports second quarter 2018 financial results 33
May 09, 2018: Chembio Diagnostics Reports First Quarter 2018 Financial Results 34
Mar 08, 2018: Chembio Diagnostics Reports Fourth Quarter and Full Year 2017 Financial Results 35
Nov 08, 2017: Chembio Diagnostics Reports Third Quarter 2017 Financial Results 36
Aug 09, 2017: Chembio Diagnostics Reports Second Quarter 2017 Financial Results 38
May 09, 2017: Chembio Diagnostics Reports First Quarter 2017 Financial Results 40
Mar 07, 2017: Chembio Diagnostics Reports 2016 Financial Results 42
Corporate Communications 44
Aug 08, 2018: Chembio Diagnostics appoints Dr. Mary Lake Polan to its board of directors 44
Jul 19, 2018: Chembio Diagnostics names Christine Rousseau as vice president, corporate development 45
May 16, 2018: Chembio Diagnostics Names John Potthoff, Ph.D. to its Board of Directors 46
Dec 20, 2017: Chembio Diagnostics Announces Appointment of Neil A. Goldman as Chief Financial Officer 47
Dec 20, 2017: Chembio Diagnostics Announces Appointment of Neil A. Goldman as Chief Financial Officer 48
Aug 17, 2017: Chembio Diagnostics Announces Retirement of Chief Financial Officer 49
Jul 06, 2017: Gail S. Page Joins Chembio Diagnostics Board of Directors 50
Jan 26, 2017: Chembio Appoints Sales Executives in Latin America, Africa, Asia Pacific 51
Other Significant Developments 52
Jul 28, 2018: FIND announces new wave of activities to address the challenges threatening hepatitis C elimination through potential diagnostic technologies 52
Sep 08, 2017: Ginolis Rapid Test Assembly System Selected by Chembio Diagnostics 53
Appendix 54
Methodology 54
About GlobalData 54
Contact Us 54
Disclaimer 54

List of Tables
Chembio Diagnostic Inc, Medical Equipment, Key Facts, 2017 2
Chembio Diagnostic Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Chembio Diagnostic Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Chembio Diagnostic Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Chembio Diagnostic Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Chembio Diagnostic Inc, Deals By Market, 2012 to YTD 2018 9
Chembio Diagnostic Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Chembio Diagnostics Acquires Rights to SURE CHECK(R) HIV 1/2 Assay From StatSure Diagnostic Systems 12
Chembio Diagnostics Enters Into Licensing Agreement With RVR Diagnostics 13
Genisphere Enters Into Licensing Agreement With Chembio Diagnostics 14
Chembio Diagnostic Enters into Agreement with Bio Manguinhos 15
Chembio Diagnostic Enters into Agreement with LumiraDx 16
Chembio Diagnostic Enters into Agreement with AstraZeneca 17
Chembio Diagnostics Enters into Agreement with FIND 18
Chembio Diagnostics Enters into Co-Development Agreement with Bio-Manguinhos 19
Chembio Diagnostics Enters into Agreement with Perseus Science 20
Chembio Diagnostics Enters into Co-Development Agreement with Integrated BioTherapeutics 21
Chembio Diagnostics Enters into Agreement to Develop POC Diagnostic Tests for Dengue Fever Virus and Specific Type of Cancer 22
Chembio Enters Into Distribution Agreement With Labtest For Dual Path Platform Products 23
Chembio Diagnostic Plans to Raise USD50 Million in Public Offering of Securities 24
Chembio Diagnostics Raises USD12 Million in Public Offering of Shares 25
Chembio Diagnostics Raises USD13.8 Million in Public Offering of Shares 26
Chembio Diagnostics Completes Public Offering Of Common Stock For US$6 Million 28
Chembio Diagnostics Acquires RVR Diagnostics 29
Chembio Diagnostic Inc, Key Competitors 30
Chembio Diagnostic Inc, Key Employees 31
Chembio Diagnostic Inc, Subsidiaries 32

List of Figures
Chembio Diagnostic Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Chembio Diagnostic Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Chembio Diagnostic Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Chembio Diagnostic Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Chembio Diagnostic Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Chembio Diagnostic Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Chembio Diagnostic Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Chembio Diagnostic Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★調査レポート[Chembio Diagnostic Inc (CEMI):医療機器:M&Aディール及び事業提携情報] (コード:DATA904C7039)販売に関する免責事項を必ずご確認ください。
★調査レポート[Chembio Diagnostic Inc (CEMI):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆